Quick Answer
Lexaria Bioscience Corp. reported Net Income of -$11.90 million for fiscal year 2025.
Lexaria Bioscience Corp. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$11.90M | -105.4% |
| 2024 | -$5.80M | +13.0% |
| 2023 | -$6.66M | +8.3% |
| 2022 | -$7.27M | -80.5% |
| 2021 | -$4.03M | +1.4% |
| 2020 | -$4.08M | +1.8% |
| 2019 | -$4.16M | +37.1% |
| 2018 | -$6.61M | -242.5% |
| 2017 | -$1.93M | -51.1% |
| 2016 | -$1.28M | +35.6% |
| 2015 | -$1.98M | -27.2% |
| 2014 | -$1.56M | -189.7% |
| 2011 | -$538.2K | +2.6% |
| 2010 | -$552.5K | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| November 30, 2025 | -$1.60M | +41.0% | +57.9% |
| May 31, 2025 | -$3.79M | -112.7% | -39.7% |
| February 28, 2025 | -$2.71M | -317.7% | -0.4% |
| November 30, 2024 | -$2.70M | -129.3% | -51.7% |
| May 31, 2024 | -$1.78M | +24.9% | -174.3% |
| February 29, 2024 | -$649.5K | +50.0% | +44.9% |
| November 30, 2023 | -$1.18M | +32.8% | +50.3% |
| May 31, 2023 | -$2.37M | +0.5% | -82.7% |
- Lexaria Bioscience Corp. showed a decrease of -105.4% in Net Income compared to the prior fiscal year.
- Over the 2010–2025 period, Lexaria Bioscience Corp.’s net income has declined by 2054.3% (from -$552.5 thousand to -$11.90 million).
- The most recent figure is from Lexaria Bioscience Corp.’s fiscal year 2025 report (Form 10-K), filed with the SEC on November 28, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: